Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9436464rdf:typepubmed:Citationlld:pubmed
pubmed-article:9436464lifeskim:mentionsumls-concept:C1155065lld:lifeskim
pubmed-article:9436464lifeskim:mentionsumls-concept:C1332709lld:lifeskim
pubmed-article:9436464lifeskim:mentionsumls-concept:C1413246lld:lifeskim
pubmed-article:9436464pubmed:issue1lld:pubmed
pubmed-article:9436464pubmed:dateCreated1998-2-11lld:pubmed
pubmed-article:9436464pubmed:abstractTextOur previous study demonstrated that CD9 is expressed on most mature naive T-cells and delivers a potent costimulatory signal that functions independently of CD28. Here, we investigated whether this CD9-mediated signal is different from the CD28-mediated signal in the mode of costimulation and whether both signals function synergistically for T-cell activation. Anti-CD9 or anti-CD28 monoclonal antibody (mAb) increased [3H]TdR incorporation of naive T-cells in the absence of antigen-presenting cells (APC) when coimmobilized with submitogenic doses of anti-CD3 mAb. The levels of costimulation induced by ligation of CD9 and CD28 were comparable. However, the costimulatory effect differed between soluble anti-CD9 and CD28 mAb. A soluble form of anti-CD28 mAb could costimulate anti-CD3-triggered T-cells, whereas soluble anti-CD9 mAb failed to costimulate. Although anti-CD28 costimulated naive T-cells treated with phorbol myristate acetate (PMA) instead of anti-CD3 mAb, a combination of PMA plus anti-CD9 mAb could not induce T-cell activation. The combined costimulation of anti-CD3-triggered T-cells with anti-CD9 and anti-CD28 mAbs resulted in strikingly enhanced [3H]TdR uptake and lymphokine (IL-2 and IFN-gamma) production when compared to those induced by each costimulation. These results suggest that CD9 and CD28 induce T-cell costimulation using different signaling pathways, thereby inducing synergy in T-cell activation.lld:pubmed
pubmed-article:9436464pubmed:languageenglld:pubmed
pubmed-article:9436464pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:citationSubsetIMlld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9436464pubmed:statusMEDLINElld:pubmed
pubmed-article:9436464pubmed:monthJunlld:pubmed
pubmed-article:9436464pubmed:issn0165-2478lld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:KEYYlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:KobayashiMMlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:FujiwaraHHlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:HamaokaTTlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:AbeRRlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:WooV LVLlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:YashiroYYlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:NebelUUlld:pubmed
pubmed-article:9436464pubmed:authorpubmed-author:Toyo-okaKKlld:pubmed
pubmed-article:9436464pubmed:issnTypePrintlld:pubmed
pubmed-article:9436464pubmed:volume58lld:pubmed
pubmed-article:9436464pubmed:ownerNLMlld:pubmed
pubmed-article:9436464pubmed:authorsCompleteYlld:pubmed
pubmed-article:9436464pubmed:pagination19-23lld:pubmed
pubmed-article:9436464pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:meshHeadingpubmed-meshheading:9436464-...lld:pubmed
pubmed-article:9436464pubmed:year1997lld:pubmed
pubmed-article:9436464pubmed:articleTitleSynergy between CD28 and CD9 costimulation for naive T-cell activation.lld:pubmed
pubmed-article:9436464pubmed:affiliationBiomedical Research Center, Osaka University Medical School, Japan.lld:pubmed
pubmed-article:9436464pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9436464pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12487entrezgene:pubmedpubmed-article:9436464lld:entrezgene
entrez-gene:12527entrezgene:pubmedpubmed-article:9436464lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9436464lld:pubmed